Seres Therapeutics (MCRB) Long-Term Investments (2016 - 2024)

Seres Therapeutics has reported Long-Term Investments for 9 years, with the latest figure at $1.4 million in Q1 2024.

• Quarterly Long-Term Investments changed 0.0% year-over-year to $1.4 million in Q1 2024, while the trailing twelve-month figure through Mar 2024 was $1.4 million (changed 0.0% YoY) and the FY2023 annual result came in at $1.4 million, changed 0.0% from the prior year.
• Long-Term Investments steadied at $1.4 million in Q1 2024 per MCRB's latest filing, from $1.4 million in the prior quarter.
• Over five years, Long-Term Investments peaked at $49.8 million in Q4 2020 and troughed at $1.4 million in Q1 2020.
• A 5-year average of $7.1 million and a median of $1.4 million in 2021 frame the typical range for Long-Term Investments.
• The sharpest annual moves came in 2020 and 2021: Long-Term Investments jumped 3458.93% in 2020, then plunged 97.19% in 2021.
• Over 5 years, Long-Term Investments stood at $49.8 million in 2020, then slumped by 97.19% to $1.4 million in 2021, then changed by 0.0% to $1.4 million in 2022, then changed by 0.0% to $1.4 million in 2023, then changed by 0.0% to $1.4 million in 2024.
• According to Business Quant data, Long-Term Investments over the past three periods registered $1.4 million, $1.4 million, and $1.4 million for Q1 2024, Q4 2023, and Q3 2023 respectively.